Clene Inc. (CLNN) CEO Rob Etherington On Neurodegenerative Disease
Nicole hosts Rob Etherington, the CEO of the clinical-stage biopharmaceutical company Clene (CLNN), to discuss the company’s latest progress on its treatments for Parkinson’s and…
View clip